Join renowned interventional cardiologists Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) for an exclusive preview of ACC.25's most significant late-breaking science. 

This episode of View from the Thoraxcenter delivers authoritative analysis of pivotal cardiovascular trials set to revolutionize clinical practice and research. Elevate your conference experience with this essential preview, where Prof Van Mieghem and Dr Daemen provide evidence-based insights that expertly contextualize each trial within today's cardiovascular landscape. Their seasoned perspective offers valuable clarity on how these groundbreaking findings will directly influence patient care protocols and shape the future of cardiology.

Trials covered include:
PROTECTED-TAVI
Evolut Low Risk: 5 Year Outcomes
TRILUMINATE
FLAVOUR II
FAME 3: 5 Year Outcomes
ECLIPSE
ALTSHOCK II
Comparison of DAPT Duration After Stenting in High and Low Bleeding Risk Populations
Clopidogrel Vs Aspirin Post-PCI in Patients with High Ischaemic Risk
DapaTAVI
FAIR-HF2
FRESH-UP